Business
Baird, klinik denemelerindeki başarısızlıkların ardından Mereo BioPharma hisse fiyat hedefini 8 dolardan 1 dolara düşürdü
SOURCE:Investing Türkiye|BY:Investing.com
Failed to fetch content: Request failed with error code 403
Failed to fetch content: Request failed with error code 403